Yesterday I gave grand rounds lecture at @NJHealth about the Omicron Variant: molecular biology, epidemiology, and clinical pearls.

Here's the video & link to download my slides.
🎥
📂 onepagericu.com/blog/grand-rou…
Google says AH-MUH-KRAN is 🇺🇸 & OH-MU-KRON is 🇬🇧
Oversimplified..

In ancient Greek, there were 2 letters pronounced similarly:
Ω made a long Oooo - it was called big O or O Mega
Ο made a short Oo - it was called little O or O Micron

Thus, OH-MI-KRON is probably more accurate
2/ Image
To understand Omicron, we need to understand pandemic surveillance:

A sick person 🤒 gets COVID tested.
The (+) results get sequenced (depending on where in the 🌎 ) & published to @GISAID (or other platform).
Sequences are used by researchers globally, such as @nextstrain.
3/ Image
Using @nextstrain to analyze those surveillance sequences we can watch the evolution of Omicron unfold:

Note the appearance of variants, particularly Delta in Summer 2021.

Omicron appears in October/November 2021.

On November 26, the WHO declared it a variant of concern.
4/
Omicron has ~50 mutations (compared to the original strain) but >30 of them are in one gene: the Spike Protein

This is worrisome because the Spike (S) protein binds to ACE2. It's also what our immune system "sees" & makes Ab against

👀 at covariants.org for more
5/
🔬 Let's look under the hood at the Spike protein mutations:
~15 in the receptor binding domain --> these *might* cause immune evasion

H655Y, N679K, P681H --> furin cleavage site mutations likely ⬆️ transmission

Q498R & N501Y --> tighter ACE2 binding, likely ⬆️ transmission
6/
One mutation is actually useful:
The TaqPath test amplifies the S gene using PCR.

In omicron the S gene won't amplify because of deletion of 2 residues (H69-, V70-). We call the failure to amplify S Gene Target Failure (SGTF).

👉🏻You may see "SGTF" as a surrogate for Omicron
7/ ImageImageImage
Because sequences are available, the effect of the mutations can be studied in vitro & in silico

Redd et al found that despite the spike protein mutations virtually all T-cell epitopes were preserved, suggesting the virus hasn't evaded T cell immunity
biorxiv.org/content/10.110…
8/ Image
Another lab (Garcia-Beltran et al) found that pseudovirus particles made with the Omicron mutant spike protein were significantly more able to infect ACE2 expressing 293T cells

2x as infectious as the Delta spike and 4x the original
medrxiv.org/content/10.110…

That's worrisome..
9/ Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Nick Mark MD

Nick Mark MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @nickmmark

27 Nov
There’s a new SARS-CoV-2 variant of concern: Omicron (aka B.1.1.529) #OmicronVariant

What is this Omicron COVID variant & is the panic of it justified? (spoiler alert: no)

A short #OmicronExplainer 🧵 about what we actually know, what we suspect, & what’s still unknown.
1/
4 reasons Omicron is worrisome:
1️⃣ it is spreading rapidly in South Africa (known)
2️⃣ it is highly mutated (known)
3️⃣some mutations likely increase transmissibility (suspected)
4️⃣others *may* allow it to evade existing immunity or vaccines (unknown)

We’ll talk about all 4...
2/
First some nomenclature:
B.1.1.529 (its Pango lineage) is the same as “Omicron" (WHO declared it a variant of concern & assigned a Greek letter) #OmicronVariant
It’s also known as K21 (Nextstrain clade)

It’s erroneously been called the #NuVariant ... yeah that’s not a thing
3/
Read 16 tweets
9 Nov
Medicine has thousands of eponyms. Most are named for doctors but a few eponyms honor patients.

For example, Bacitracin, named for the bacteria Bacillus subtilis var Tracy, was first identified in a little girl “Tracy I.”

New post & medical history🧵
1/
onepagericu.com/blog/magnanimo…
Hieronymus Karl Friedrich Freiherr von Münchhausen, a German Baron, was legendary for telling stories of his adventures in the Russian Cavalry during the Russo-Turkish War.
(even the dogs look entertained!)
Notably he was *NOT* regarded as a liar but as a great story-teller!
2/
A German writer & con-artist, Rudolf Erich Raspe, created a fictional character Baron Munchausen loosely based on Baron Münchhausen (note the spelling: u not ü)

Munchausen had incredible adventures such as riding a cannonball, fighting a 40 foot crocodile, & going to the Moon
3/
Read 23 tweets
5 Nov
💊Exciting news today about another oral therapy for early COVID: reduced hospitalization & mortality.

Here’s a Deep dive 🧵 on the new PF-07321332 protease inhibitor (“Paxlovid”) & the very impressive results announced from the EPIC-HR trial.
TL/DR: this is a big deal.
1/
What the heck is PF-07321332?

All coronaviruses produce a polypeptide that must be cleaved by a protease into 11 proteins. Without this protease the virus can’t co-opt cellar machinery & reproduce.

PF-07321332 Inhibits the viral main protease (Mpro).
2/

pdb101.rcsb.org/motm/242
Specifically PF-07321332 binds to the catalytic site of Mpro.

Mpro is a great target because there are unique features of Mpro not found in *any* human enzymes & because spike protein mutations wouldn’t confer resistance.

In short, an ideal drug🎯
3/

medrxiv.org/content/10.110…
Read 15 tweets
3 Nov
🚨Results of the #ITECH RCT in Malaysia 🇲🇾 are in & it’s yet another NEGATIVE result for ivermectin:
-n=500 high risk outpatients w/COVID randomized to 0.4 mg/kg IVM x5 days vs SOC
-no difference in rate of progression or time to recovery
-3x more adverse events w/ ivermectin
1/ Image
I-TECH was an open label RCT of IVM (0.4 mg/kgx5 days) vs standard of care (SOC)

It enrolled high risk outpatients (>50 yo w/ ≥ 1 comorbidity) w/in 7 days of COVID symptoms

In summary, HIGH risk pts given HIGH dose IVM EARLY & adequately powered 🤔
clinicaltrials.gov/ct2/show/NCT04…
2/ ImageImageImageImage
We don’t have the full results yet but based on the 🇲🇾 Ministry of Health data this was a NEGATIVE trial.
- IVM recipients did numerically worse: 21.2% progressed to severe disease vs 17.9% receiving SOC (OR 1.29 CI 0.8-2.0)
- time to progression was similar: 2.9 vs 3 days
3/ Image
Read 8 tweets
30 Oct
If you think no one is getting rich off of ivermectin, definitely don't watch this video from FLCCC founder Dr. Fred Wagshul.

For just $276 (cash only, no insurance), this quack will prescribe ivermectin "no questions asked." Don't worry he's got "plenty of product."

Yikes!
1/
His website makes it really clear.

You just fill out this form (including your SSN) and send it to a not at all sketchy gmail address.

Then you pay $211 for a 3 minute phone call and get your prescription. Plus $75 for a followup. Then $75 recurring every 6 months.
2/
There are quite a few 🚩 on this website.

Aside from referring to $276 telehealth prescriptions for ivermectin as "preventive maintenance" this pulmonologist is also apparently an expert in... interstitial cystitis?

So pulm and urology under one roof. Not at all sketchy.
3/
Read 7 tweets
27 Oct
Interesting results from the #TOGETHER RCT of #fluvoxamine vs placebo in n=1497 high risk outpatients in 🇧🇷 with #COVID:
-people who received fluvoxamine were less likely to require extended ED visit or hospitalization (11% vs 16%, RR 0.68 CI 0.52-0.88)
thelancet.com/journals/langl…
1/ ImageImageImageImage
TOGETHER was a large, multi-arm adaptive platform DB-RCT done in 🇧🇷 Brazil from June 2020 to Jan 2021.

Patients were identified after testing positive, stratified by age (>50 or <50 yo) & randomized to fluvoxamine 100 mg BID x 10 days vs placebo.
2/
It builds upon 2 studies:
-an observational study in 🇫🇷 that found better outcomes among inpts already taking SSRIs
nature.com/articles/s4138…
-a small n=152 RCT done in 🇺🇸 showing a decrease in clinical deterioration among outpts randomized to Fluvoxamine
jamanetwork.com/journals/jama/…
3/ ImageImageImageImage
Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(